Abnormal D-serine metabolism in amyotrophic lateral sclerosis

Jumpei Sasabe, Sadakazu Aiso

Research output: Chapter in Book/Report/Conference proceedingChapter

2 Citations (Scopus)

Abstract

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease, whose pathology is characterized by death of upper and lower motor neurons, inclusion bodies in remaining neurons and glia, and glial activation around the neurons. The pathophysiological mechanisms underlying ALS are multifactorial and remain to be fully elucidated. Here, we review D-serine-related findings in ALS and delineate how D-serine metabolism is disturbed and why such D-serine derangement could potentially be toxic to motoneurons. Motoneurons are vulnerable to glutamate excitotoxicity. D-Serine is an endogenous coagonist with glutamate for stimulation of N-methyl-D-aspartate (NMDA) subtype glutamate receptors. D-Serine accumulates progressively in the spinal cord of a mouse model of familial ALS, in which human superoxide dismutase 1 (SOD1) with a mutation G93A is overexpressed. Such accumulation was also reported in a few patients with sporadic ALS or familial ALS with A4T-SOD1. The D-serine accumulation in the mouse model is explained by a combination of increased D-serine-producing enzyme and decreased D-serine-degrading enzyme, D-amino acid oxidase (DAO), which are both found in activated glial cells. Importantly, a dominant negative mutation D199W in DAO has been reported in patients with familial ALS that exhibits classical motor symptoms of ALS. The mutant D199W-DAO increases autophagy in motor neurons through activation of NMDA receptors by D-serine, which results in motoneuronal apoptosis. Furthermore, a null mutation G181R in DAO significantly increases D-serine level in the spinal cord with mild motoneuronal degeneration in mice. Collectively, aberrant metabolism of D-serine in glial cells may trigger motoneuronal degeneration, which sheds light on a unique aspect of ALS pathophysiology.

Original languageEnglish
Title of host publicationD-Amino Acids
Subtitle of host publicationPhysiology, Metabolism, and Application
PublisherSpringer Japan
Pages137-149
Number of pages13
ISBN (Electronic)9784431560777
ISBN (Print)9784431560753
DOIs
Publication statusPublished - 2016 Jan 1
Externally publishedYes

Fingerprint

Metabolism
Serine
D-Amino-Acid Oxidase
Neurons
Superoxide Dismutase
Glutamic Acid
Chemical activation
Neurodegenerative diseases
Poisons
Glutamate Receptors
Pathology
N-Methylaspartate
N-Methyl-D-Aspartate Receptors
Enzymes
Apoptosis

Keywords

  • Amyotrophic lateral sclerosis
  • D-amino acid oxidase
  • D-Serine
  • Motoneuron
  • Serine racemase

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)

Cite this

Sasabe, J., & Aiso, S. (2016). Abnormal D-serine metabolism in amyotrophic lateral sclerosis. In D-Amino Acids: Physiology, Metabolism, and Application (pp. 137-149). Springer Japan. https://doi.org/10.1007/978-4-431-56077-7_9

Abnormal D-serine metabolism in amyotrophic lateral sclerosis. / Sasabe, Jumpei; Aiso, Sadakazu.

D-Amino Acids: Physiology, Metabolism, and Application. Springer Japan, 2016. p. 137-149.

Research output: Chapter in Book/Report/Conference proceedingChapter

Sasabe, J & Aiso, S 2016, Abnormal D-serine metabolism in amyotrophic lateral sclerosis. in D-Amino Acids: Physiology, Metabolism, and Application. Springer Japan, pp. 137-149. https://doi.org/10.1007/978-4-431-56077-7_9
Sasabe J, Aiso S. Abnormal D-serine metabolism in amyotrophic lateral sclerosis. In D-Amino Acids: Physiology, Metabolism, and Application. Springer Japan. 2016. p. 137-149 https://doi.org/10.1007/978-4-431-56077-7_9
Sasabe, Jumpei ; Aiso, Sadakazu. / Abnormal D-serine metabolism in amyotrophic lateral sclerosis. D-Amino Acids: Physiology, Metabolism, and Application. Springer Japan, 2016. pp. 137-149
@inbook{761d648ee79a4bc5808a7872db48a263,
title = "Abnormal D-serine metabolism in amyotrophic lateral sclerosis",
abstract = "Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease, whose pathology is characterized by death of upper and lower motor neurons, inclusion bodies in remaining neurons and glia, and glial activation around the neurons. The pathophysiological mechanisms underlying ALS are multifactorial and remain to be fully elucidated. Here, we review D-serine-related findings in ALS and delineate how D-serine metabolism is disturbed and why such D-serine derangement could potentially be toxic to motoneurons. Motoneurons are vulnerable to glutamate excitotoxicity. D-Serine is an endogenous coagonist with glutamate for stimulation of N-methyl-D-aspartate (NMDA) subtype glutamate receptors. D-Serine accumulates progressively in the spinal cord of a mouse model of familial ALS, in which human superoxide dismutase 1 (SOD1) with a mutation G93A is overexpressed. Such accumulation was also reported in a few patients with sporadic ALS or familial ALS with A4T-SOD1. The D-serine accumulation in the mouse model is explained by a combination of increased D-serine-producing enzyme and decreased D-serine-degrading enzyme, D-amino acid oxidase (DAO), which are both found in activated glial cells. Importantly, a dominant negative mutation D199W in DAO has been reported in patients with familial ALS that exhibits classical motor symptoms of ALS. The mutant D199W-DAO increases autophagy in motor neurons through activation of NMDA receptors by D-serine, which results in motoneuronal apoptosis. Furthermore, a null mutation G181R in DAO significantly increases D-serine level in the spinal cord with mild motoneuronal degeneration in mice. Collectively, aberrant metabolism of D-serine in glial cells may trigger motoneuronal degeneration, which sheds light on a unique aspect of ALS pathophysiology.",
keywords = "Amyotrophic lateral sclerosis, D-amino acid oxidase, D-Serine, Motoneuron, Serine racemase",
author = "Jumpei Sasabe and Sadakazu Aiso",
year = "2016",
month = "1",
day = "1",
doi = "10.1007/978-4-431-56077-7_9",
language = "English",
isbn = "9784431560753",
pages = "137--149",
booktitle = "D-Amino Acids",
publisher = "Springer Japan",
address = "Japan",

}

TY - CHAP

T1 - Abnormal D-serine metabolism in amyotrophic lateral sclerosis

AU - Sasabe, Jumpei

AU - Aiso, Sadakazu

PY - 2016/1/1

Y1 - 2016/1/1

N2 - Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease, whose pathology is characterized by death of upper and lower motor neurons, inclusion bodies in remaining neurons and glia, and glial activation around the neurons. The pathophysiological mechanisms underlying ALS are multifactorial and remain to be fully elucidated. Here, we review D-serine-related findings in ALS and delineate how D-serine metabolism is disturbed and why such D-serine derangement could potentially be toxic to motoneurons. Motoneurons are vulnerable to glutamate excitotoxicity. D-Serine is an endogenous coagonist with glutamate for stimulation of N-methyl-D-aspartate (NMDA) subtype glutamate receptors. D-Serine accumulates progressively in the spinal cord of a mouse model of familial ALS, in which human superoxide dismutase 1 (SOD1) with a mutation G93A is overexpressed. Such accumulation was also reported in a few patients with sporadic ALS or familial ALS with A4T-SOD1. The D-serine accumulation in the mouse model is explained by a combination of increased D-serine-producing enzyme and decreased D-serine-degrading enzyme, D-amino acid oxidase (DAO), which are both found in activated glial cells. Importantly, a dominant negative mutation D199W in DAO has been reported in patients with familial ALS that exhibits classical motor symptoms of ALS. The mutant D199W-DAO increases autophagy in motor neurons through activation of NMDA receptors by D-serine, which results in motoneuronal apoptosis. Furthermore, a null mutation G181R in DAO significantly increases D-serine level in the spinal cord with mild motoneuronal degeneration in mice. Collectively, aberrant metabolism of D-serine in glial cells may trigger motoneuronal degeneration, which sheds light on a unique aspect of ALS pathophysiology.

AB - Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease, whose pathology is characterized by death of upper and lower motor neurons, inclusion bodies in remaining neurons and glia, and glial activation around the neurons. The pathophysiological mechanisms underlying ALS are multifactorial and remain to be fully elucidated. Here, we review D-serine-related findings in ALS and delineate how D-serine metabolism is disturbed and why such D-serine derangement could potentially be toxic to motoneurons. Motoneurons are vulnerable to glutamate excitotoxicity. D-Serine is an endogenous coagonist with glutamate for stimulation of N-methyl-D-aspartate (NMDA) subtype glutamate receptors. D-Serine accumulates progressively in the spinal cord of a mouse model of familial ALS, in which human superoxide dismutase 1 (SOD1) with a mutation G93A is overexpressed. Such accumulation was also reported in a few patients with sporadic ALS or familial ALS with A4T-SOD1. The D-serine accumulation in the mouse model is explained by a combination of increased D-serine-producing enzyme and decreased D-serine-degrading enzyme, D-amino acid oxidase (DAO), which are both found in activated glial cells. Importantly, a dominant negative mutation D199W in DAO has been reported in patients with familial ALS that exhibits classical motor symptoms of ALS. The mutant D199W-DAO increases autophagy in motor neurons through activation of NMDA receptors by D-serine, which results in motoneuronal apoptosis. Furthermore, a null mutation G181R in DAO significantly increases D-serine level in the spinal cord with mild motoneuronal degeneration in mice. Collectively, aberrant metabolism of D-serine in glial cells may trigger motoneuronal degeneration, which sheds light on a unique aspect of ALS pathophysiology.

KW - Amyotrophic lateral sclerosis

KW - D-amino acid oxidase

KW - D-Serine

KW - Motoneuron

KW - Serine racemase

UR - http://www.scopus.com/inward/record.url?scp=85017089968&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85017089968&partnerID=8YFLogxK

U2 - 10.1007/978-4-431-56077-7_9

DO - 10.1007/978-4-431-56077-7_9

M3 - Chapter

SN - 9784431560753

SP - 137

EP - 149

BT - D-Amino Acids

PB - Springer Japan

ER -